Name: Personalized Drug Screening for Functional Tumor Profiling (Elements in Molecular Oncology) (en Inglés)
SKU: 54179800
Price: 648.79 MXN
Availability: InStock
Author: El-Khoury, Victoria ; Michel, Tatiana ; Kim, Hichul
ISBN: 9781009016933

portada Personalized Drug Screening for Functional Tumor Profiling (Elements in Molecular Oncology) (en Inglés)

Personalized Drug Screening for Functional Tumor Profiling (Elements in Molecular Oncology) (en Inglés)

Formato

Libro Físico

Autor

Victoria El-Khoury

Tatiana Michel

Hichul Kim

Editorial

Cambridge University Press

Año

2022

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

22.9x15.2x0.2 cm

Peso

0.05 kg.

ISBN13

9781009016933

Categorías

Oncología

Personalized Drug Screening for Functional Tumor Profiling (Elements in Molecular Oncology) (en Inglés)

Victoria El-Khoury (Autor) · Tatiana Michel (Autor) · Hichul Kim (Autor) · Cambridge University Press · Tapa Blanda

Libro Nuevo Importado

Envío: 14 a 19 días háb.

$ 1,179.62$ 648.79

-45%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan más de 100 unidades

$ 648.79

¡Envío Gratis! Llega entre el 30 Sep y el 08 Oct a CUAUHTÉMOC, Ciudad de México. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Personalized Drug Screening for Functional Tumor Profiling (Elements in Molecular Oncology) (en Inglés)"

Despite considerable advances in our understanding of the biology that underlies tumor development and progression of cancer and the rapidly evolving field of personalized medicine, cancer is still one of the deadliest diseases. Many cancer patients have benefited from the survival improvements observed with targeted therapies but only a small subset of patients receiving targeted drugs experience an objective response. Because cancer is a complex and heterogeneous disease, the search for effective cancer treatments will need to address not only patient-specific molecular defects but also aspects of the tumor microenvironment. The functional tumor profiling directly measures the cellular phenotype, in particular tumor growth, in response to drugs using patient-derived tumor models and might be the next step toward precision oncology. In this Element, the authors discuss the personalized drug screening as a novel patient stratification strategy for the determination of individualized treatment choices in oncology.